Immunotherapy in bee-sting anaphylaxis. Use of honeybee venom.
After nine months of immunotherapy with commercially prepared wholebody bee extract, a beekeeper's wife experienced anaphylaxis after a controlled bee-sting challenge. High risk of future bee stings prompted a decision to attempt desensitization with honeybee venom. This was extracted from the bee into Coca solution and administered parenterally in increasing daily doses until an equivalent of one venom sac was given per day. This maintenance dosage was continued for a month. Anaphylaxis did not occur after another bee-sting challenge. Therapy has been maintained with venom. With this treatment, there has been an increase in the level of IgG-blocking antibody and a fall in IgE titer to bee venom (radioallergosorbent test [RAST]).
D000328:Adult; D000707:Anaphylaxis / Q000188:drug therapy* / Q000209:etiology; D000906:Antibodies / Q000032:analysis; D000936:Antigen-Antibody Complex; D001516:Bees; D003888:Desensitization, Immunologic; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D007167:Immunotherapy; D007271:Injections, Intradermal; D007299:Insect Bites and Stings / Q000150:complications*; D013997:Time Factors; D014688:Venoms / Q000008:administration & dosage / Q000627:therapeutic use*
D000906:Antibodies; D000936:Antigen-Antibody Complex; D014688:Venoms; D007073:Immunoglobulin E